glp-1 study Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Professor Receives Grant to Study

State leaders say soaring costs forced the change, especially as Medicaid faces mounting funding pressure under the Trump administration

If youre comfortable with a hands-off, fast, and affordable GLP-1 experience and can look past the documentation gaps, Eden offers real value

J.HornD

The FDA issued a February 2026 statement that it "intends to take action against non-FDA-approved GLP-1 drugs." As brand-name supply stabilizes, the legal justification for mass-compounding (which requires a drug shortage) weakens

And yet here it is, more than 100,000 users of Ozempic and similar drugs with a reasonable control group, and the outcome is equivocal